Guardian Pharmacy Services, Inc.
NYQ: GRDNLive Quote
About Guardian Pharmacy Services, Inc.
Healthcare
Medical Care Facilities
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
📊 Fundamental Analysis
Guardian Pharmacy Services, Inc. demonstrates a profit margin of 3.4%, which is below the sector average, suggesting competitive pressure.
The company recently reported 17.4% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is 26.6%, which exceeds the Healthcare sector average, reflecting efficient capital allocation.
At a current price of $39.15, GRDN currently trades near the top of its 52-week range (90%) (Range: $19.17 - $41.36).
💰 Valuation Insight
GRDN trades at a 100.8% premium to the sector average PE of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
✅
Revenue Growth
Excellent
⚠️
Return on Equity
Moderate
Key Financials
Market Cap
$2.65B
Trailing P/E
50.19
Forward P/E
28.91
Beta (5Y)
--
52W High
$41.36
52W Low
$19.17
Avg Volume
403K
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App